We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.57%
AUM
$2.29T
AUM Growth
+$147B
Cap. Flow
+$28.3B
Cap. Flow %
1.24%
Top 10 Hldgs %
14.11%
Holding
4,176
New
102
Increased
2,933
Reduced
915
Closed
113

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$1.56B
2
INVH icon
Invitation Homes
INVH
+$932M
3
MSFT icon
Microsoft
MSFT
+$818M
4
LUMN icon
Lumen
LUMN
+$746M
5
BDX icon
Becton Dickinson
BDX
+$706M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$2.53B
2
LVLT
Level 3 Communications Inc
LVLT
+$1.58B
3
KITE
Kite Pharma, Inc.
KITE
+$736M
4
SFR
Starwood Waypoint Homes
SFR
+$725M
5
LRCX icon
Lam Research
LRCX
+$452M

Sector Composition

Rank Sector Weight
1 Financials 15.99%
2 Technology 15.47%
3 Healthcare 12.33%
4 Industrials 10.79%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALT icon
3726
Altimmune
ALT
$552M
$544K ﹤0.01%
9,120
+55
+0.6% +$3.51K
SEEL
3727
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$541K ﹤0.01%
3
– –
CTHR
3728
DELISTED
Charles & Colvard Ltd
CTHR
$539K ﹤0.01%
39,909
-3,246
-8% -$36K
BIOC
3729
DELISTED
Biocept, Inc.
BIOC
$536K ﹤0.01%
86
– –
SPRO icon
3730
Spero Therapeutics
SPRO
$67.7M
$534K ﹤0.01%
+45,489
New +$558K
RAS
3731
DELISTED
RAIT Financial Trust
RAS
$533K ﹤0.01%
1,421,181
-8,657,375
-86% -$3.91M
MAYS icon
3732
J.W. Mays
MAYS
$78.1M
$530K ﹤0.01%
13,955
-2,000
-13% -$76.3K
CPHC icon
3733
Canterbury Park Holding Corp
CPHC
$78.8M
$529K ﹤0.01%
+32,134
New +$447K
IVOG icon
3734
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.62B
$529K ﹤0.01%
7,900
-498
-6% -$32.5K
CZFC
3735
DELISTED
Citizens First Corporation
CZFC
$528K ﹤0.01%
21,996
+200
+0.9% +$4.7K
STKS icon
3736
The ONE Group
STKS
$56.2M
$527K ﹤0.01%
220,377
+25,027
+13% +$46K
SUNW
3737
DELISTED
Sunworks, Inc.
SUNW
$524K ﹤0.01%
71,368
+3,386
+5% +$28.9K
REFR icon
3738
Research Frontiers
REFR
$14M
$523K ﹤0.01%
502,797
-22,723
-4% -$24.7K
MBII
3739
DELISTED
Marrone Bio Innovations, Inc.
MBII
$521K ﹤0.01%
473,032
+84,377
+22% +$86.3K
APEX
3740
DELISTED
Apex Global Brands Inc. Common Stock
APEX
$521K ﹤0.01%
9,151
-2,492
-21% -$174K
IVOV icon
3741
Vanguard S&P Mid-Cap 400 Value ETF
IVOV
$1.34B
$518K ﹤0.01%
8,508
+222
+3% +$13.3K
ZSAN
3742
DELISTED
Zosano Pharma Corporation
ZSAN
$515K ﹤0.01%
1,415
-393
-22% -$197K
ANTH
3743
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$512K ﹤0.01%
309,889
-49,862
-14% -$85.8K
OESX icon
3744
Orion Energy Systems
OESX
$41M
$510K ﹤0.01%
57,965
-833
-1% -$7.66K
AM icon
3745
Antero Midstream
AM
$10.4B
$509K ﹤0.01%
+25,842
New +$480K
SODA
3746
DELISTED
SodaStream International Ltd
SODA
$508K ﹤0.01%
7,227
+399
+6% +$26.4K
CETX icon
3747
Cemtrex
CETX
$4.25M
– –
0
– –
SAL
3748
DELISTED
Salisbury Bancorp, Inc.
SAL
$506K ﹤0.01%
+22,554
New +$513K
AEMD icon
3749
Aethlon Medical
AEMD
$1.75M
$501K ﹤0.01%
37
+19
+106% +$231K
VERO
3750
DELISTED
Venus Concept
VERO
$498K ﹤0.01%
+44
New +$681K
148 149
150
151 152

Similar funds

Norges Bank
Norges Bank Oslo, Norway $935B AUM
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
CWM
CIBC World Markets New York $20.8B AUM
VRS
Virginia Retirement Systems Richmond, Virginia $16.8B AUM 25.91% 1-Year Est. Return
FAF
Första AP-fonden Stockholm, Sweden $16.8B AUM 29.64% 1-Year Est. Return
BGIM
Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

Vanguard Group's Q4 2017 Portfolio in Review

As of Q4 2017, Vanguard Group held 4,176 positions worth $2.29T, up 6.9% from $2.14T the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Vanguard Group's Q4 2017 filing shows 102 new, 2,933 increased, 915 reduced and 113 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 7,351,313 shares worth $386M. The largest sale was CR Bard Inc., an estimated $2.53B.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Vanguard Group's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 7,351,313 shares worth $386M.
  • Vanguard Group added most to Alibaba in Q4 2017, an estimated $1.56B increase.
  • Vanguard Group's biggest Q4 2017 reduction was Lam Research, cutting an estimated $452M.
  • Vanguard Group fully exited CR Bard Inc. in Q4 2017, selling an estimated $2.53B.
  • Vanguard Group's ten largest holdings make up 14% of its $2.29T portfolio in Q4 2017.
  • Vanguard Group opened 102 new positions and closed 113 in Q4 2017.
  • Vanguard Group's portfolio value rose 6.9% quarter-over-quarter to $2.29T.

Based on Vanguard Group's 13F filing for Q4 2017, filed 14 Feb 2018.